Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-14, Stock:LLY, The news for the past five days is as follows:
2018-08-07: NEWS1: Radius (RDUS) Q2 Loss Narrower Than Expected, Tymlos Sales Up.NEWS2: Radius (RDUS) Q2 Loss Narrower Than Expected, Tymlos Sales Up.NEWS3: Why Health Care Stocks Are Outshining The Techs.NEWS4: Merck and Its Peers: Analysts’ Recommendations in August.NEWS5: Q2 Earnings Drive Pharma ETFs Higher.NEWS6: Q2 Earnings Drive Pharma ETFs Higher.NEWS7: Pfizer Reports Revenue Growth in Q2 2018.NEWS8: Q2 Earnings Drive Pharma ETFs Higher.
2018-08-08: NEWS1: Notable Wednesday Option Activity: CRI, LLY, TRTN.NEWS2: Notable Wednesday Option Activity: CRI, LLY, TRTN.NEWS3: Eli Lilly Raised Its Non-GAAP Earnings Guidance for Fiscal 2018.NEWS4: AVEO Pharmaceuticals (AVEO) Q2 Loss In Line, Revenues Miss.NEWS5: AVEO Pharmaceuticals (AVEO) Q2 Loss In Line, Revenues Miss.NEWS6: Novo Nordisk (NVO) Beats Q2 Earnings and Sales Estimates.NEWS7: Novo Nordisk (NVO) Beats Q2 Earnings and Sales Estimates.NEWS8: Is Eli Lilly (LLY) a Great Dividend Play?.
2018-08-09: NEWS1: Noteworthy ETF Outflows: DHS, MO, OXY, LLY.NEWS2: Noteworthy ETF Outflows: DHS, MO, OXY, LLY.NEWS3: Nektar (NKTR) Q2 Earnings In Line, Product Sales Down Y/Y.NEWS4: Nektar (NKTR) Q2 Earnings In Line, Product Sales Down Y/Y.NEWS5: Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates.NEWS6: Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates.NEWS7: Analysts’ Recommendations for Pfizer on August 6.NEWS8: Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates.NEWS9: A Look at Recent Developments at Pfizer.
2018-08-10: NEWS1: Eli Lilly Stock History.NEWS2: Eli Lilly Stock History.NEWS3: Eli Lilly Stock History.
2018-08-13: NEWS1: Mylan Launches First Adcirca Generic, Stock Moves Up.NEWS2: Novo Nordisk’s Long-Acting Insulins: A Performance Overview.NEWS3: Can Victoza Continue to Boost Novo Nordisk’s Revenue Growth?.NEWS4: Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings.NEWS5: Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings.NEWS6: Novo Nordisk: A Financial Overview after the First Half of 2018.NEWS7: Here&apos;s Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings.NEWS8: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for August 14, 2018.NEWS9: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for August 14, 2018.

Answer: Rise